patent.fyi
Applications  /  US 2026/0355381
United States Patent Application Publication

US 2026/0355381 A1

Published
Nov 12, 2026
Filed
Apr 16, 2026
Earliest date on the face
Nov 19, 2018
Classification
A61L 15/60
First published here
Nov 19, 2026

Generated automatically. Not reviewed by a person. Not legal advice or an opinion.

Section 1 · machine-generated

What if?

Questions about how individual parts of claim 1 might be changed. A question may describe something different from what the claim language recites, or a version of it; no view is offered on which.

1.1Gel at the wound margin

What ifWhat if a protein-containing gel forms a ring on the intact skin around the wound while an absorbent pad spans the wound bed?
Claim language“placing a physiologically acceptable gelling substrate over a wound”

A viscous gel containing gelatin and sodium carboxymethylcellulose is dispensed onto intact skin around the wound. The ring fills gaps beneath the cover film, and a separate absorbent pad takes up fluid from the wound bed.

1.1Capillary uptake in polyurethane foam

What ifWhat if a flexible open-cell foam carries the protein and takes up wound fluid through its pores?
Claim language“physiologically acceptable gelling substrate”

An open-cell polyurethane foam has a thin, crosslinked collagen coating on its wound-facing surface. Interconnected pores draw in exudate by capillary action and hold it within the foam.

1.1Hyaluronate in a hydrated gel

What ifWhat if the gel contains sodium hyaluronate as its wound-contact additive and contains no protein?
Claim language“a protein or a derivative thereof”

A hydrated polyvinyl alcohol sheet contains sodium hyaluronate dispersed in its aqueous phase. The sheet conforms to the wound surface, and the hyaluronate binds water at the interface.

1.2Soluble collagen peptide release

What ifWhat if the protein derivative dissolves and diffuses out of the dressing during wear?
Claim language“is immobilized and stable on the gelling substrate”

Water-soluble collagen peptides are dispersed in a hydrated polyvinyl alcohol gel. Dissolved peptides diffuse through the gel's water phase into fluid at the wound surface.

1.2Dry fibers gel after placement

What ifWhat if a dry fibrous sheet is placed on the wound and forms a gel as it absorbs exudate?
Claim language“in a pre-gelled state”

A dry calcium alginate nonwoven carries a crosslinked collagen coating on its wound-facing fibers. Sodium ions in exudate exchange with calcium ions in the alginate, and the hydrated fibers form a soft gel.

Section 2 · machine-generated

Variations

Further arrangements of the same subject matter, described here as of the publication date at the foot of this page.

Other field of use

Hydrogel contact pad for graft transport

A sterile transport cassette holds a pre-gelled agarose pad with type I collagen covalently attached to its contact face. An excised skin graft rests dermal side down on the pad, which is hydrated with isotonic buffer before loading. A peripheral frame holds the pad in place while the sealed cassette limits moisture loss during transfer between preparation and placement.

Component substitution

Polyethylene glycol gel with immobilized gelatin

A crosslinked polyethylene glycol hydrogel forms the wound contact sheet. A fraction of the gelatin amino groups carries thiol groups, which react with vinyl sulfone groups on the polyethylene glycol and tether the gelatin during gelation. The cured sheet is washed with isotonic saline to remove soluble residues and is placed over the wound in its hydrated state.

Dextran gel with tethered collagen peptides

A crosslinked dextran hydrogel carries a short collagen-derived peptide in place of a full-length protein. A terminal cysteine on the peptide reacts with a fraction of the maleimide groups on modified dextran, and a bifunctional thiol consumes the remaining groups to form the gel network. The sheet is equilibrated in isotonic saline before placement over the wound, and the covalent tether retains the peptide in the hydrated network.

Parameter or scale variation

Small gel tiles for curved wounds

A pre-gelled sheet of calcium alginate containing covalently tethered gelatin is cast at 2 mm thickness and cut into 10 mm squares. The squares are placed in a staggered pattern with gaps of 0.5 to 1 mm between neighboring edges. Each square follows the local surface contour, and the gaps accommodate bending between squares.

Combination with existing systems

Perforated gel for negative pressure therapy

A pre-gelled polyethylene glycol contact sheet carries covalently tethered gelatin and has through-holes across its wound-facing area. A porous foam manifold sits above the sheet inside a sealed negative pressure dressing. A suction line connects the foam to a collection canister, and wound fluid passes through the holes into the foam and onward to the canister.

Automated or data-driven variant

Image guided cutting of gel sheets

A camera captures the wound and a disposable scale marker positioned beside it in the same plane. Software converts a clinician-traced wound outline to millimeter coordinates and sends the contour to an enclosed knife cutter fitted with a sterile blade and tray. The cutter trims a pre-gelled sheet bearing covalently immobilized gelatin, and the clinician places the trimmed sheet over the wound.

Specific version of a part

Collagen coated hydrogel sheet

A hydrated polyvinyl alcohol sheet carries a crosslinked collagen coating on its wound-facing side. The sheet is laid across the wound bed and held in place by a secondary cover.

Gelatin in a composite sheet

A hydrated calcium alginate sheet contains crosslinked gelatin particles distributed through its wound-facing layer. The sheet conforms to the wound surface and takes up exudate as the alginate swells.

Covalently tethered collagen peptides

Carboxyl groups on a hydrated alginate sheet are activated and coupled to amino groups on collagen peptides to form amide bonds. The sheet is then washed to remove unbound peptide and stored hydrated in a sealed pouch.

Gelatin linked within preformed hydrogel

Gelatin and a multi-arm polyethylene glycol crosslinker with activated ester end groups are mixed in aqueous buffer and cast into a sheet. Amide bonds anchor the gelatin throughout the network, and the hydrated sheet is packaged after the gel sets.

Section 3 · quoted from USPTO records

Other work

Passages reproduced word for word from two earlier-published U.S. patent documents, placed beside the language of claim 1. No characterization is offered. Each passage is marked A or B for the document it comes from; ¶ numbers are the paragraph numbers in the USPTO’s published full text of that document.

Document AUS 2011/0118645 A1
Published
May 19, 2011
Filed
Dec 12, 2008
Class
A61L 15/44
Document BUS 2017/0319740 A1
Published
Nov 9, 2017
Filed
Nov 12, 2015
Class
A61L 27/12
Claim 1
Document A
Document B
1.1placing a physiologically acceptable gelling substrate over a wound, the gelling substrate comprising a protein or a derivative thereof
The present applicator comprises a rigid body (20) having a rigid body enclosure (30) for receiving a wound dressing, and an ejector (40) for ejecting the wound dressing from the rigid body enclosure and onto a patient's wound.
A · US 2011/0118645 A1 · abstract
The invention described here relates to a method for the incorporation of the above nano- or microspheres into electrospun fibers consisting of PLA under formation of 3D mats suitable as antimicrobial and regenerative dressings for wound healing.
B · US 2017/0319740 A1 · ¶ 31
1.2wherein the protein or derivative thereof is immobilized and stable on the gelling substrate, the gelling substrate in a pre-gelled state.

An empty cell means only that no passage was reproduced there.

Statements in these documents
A problem associated with this type of known wound dressing application system is that the means for applying the wound dressing to the patient's skin is flexible, which means that it can be difficult to handle the dressing and to accurately position it to cover a wound.
A · US 2011/0118645 A1 · ¶ 3
Also, the use of flexible packaging sheets does not adequately protect the wound dressing from damage during transit and general handling of the wound dressing delivery systems.
A · US 2011/0118645 A1 · ¶ 3
A further aspect of this invention concerns the incorporation of such nano- or microparticles, after encapsulation of retinol (“retinol/aCa-polyP nano- or microspheres”), into wound dressings and related materials that are made, e.g., by electrospinning.
B · US 2017/0319740 A1 · ¶ 1
The resulting, inventive retinol/aCa-polyP nano- or microspheres fiber mats show antimicrobial and wound healing properties and was found to increase the expression of the genes encoding for leptin and the leptin receptor, as well as the fatty acid binding protein 4 (FABP4) in a synergistic manner.
B · US 2017/0319740 A1 · ¶ 1
Cite aspatent.fyi, US 2026/0355381 A1, claim 1, first published 2026-11-19T10:59:45-05:00, https://patent.fyi/US20260355381/, SHA-256 adb120ead5538c4215c86c27fee4a314f79804566366a1ff63a70f0ba4dea7ad
First published
Permanent addresshttps://patent.fyi/US20260355381/
Content fingerprint (SHA-256)adb120ead5538c4215c86c27fee4a314f79804566366a1ff63a70f0ba4dea7ad
Methodv2026-11-18.2 · automated, not reviewed by a person
Correctionscorrections@patent.fyi